Up
2006P-0300:
ANDA Suitability for Glycoprrolate Tablets, USP 1.5 mg
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Document #
|
| Received Date
|
| Filed
Date
|
| Submitter Code
|
| Submitter
|
| FR
Date
|
| FR
Page
|
| Comment Date
|
| Files
|
| Remarks
|
|
|
|
|
|
CP1 |
|
07/28/2006
|
|
07/28/2006
|
|
Private Industry
|
|
Lachman Consultant
Services Inc. |
|
|
|
|
|
|
|
Table
of Contents |
|
|
|
|
Signature: |
|
Robert W. Pollock
|
|
|
|
ACK1 |
|
07/28/2006
|
|
07/28/2006
|
|
Federal Government |
|
FDA/DDM to Lachman
Consultant Services Inc. |
|
|
|
|
|
|
|
pdf |
|
|
|
|
|
|
Signature: |
|
Lyle D. Jaffe |
|
Top | Up
Page last updated
August 22, 2006
kk
Dockets Home Page | Dockets
Contacts and Location | Operating
Status | Item
Code Definitions | Federal
Register
FDA Home Page | Search
FDA Site | FDA A-Z Index
| Contact FDA
FDA/Dockets Management |